Delphine Gabrielle Josette Rea

Title: Delphine Gabrielle Josette Rea: Innovator in Immunotherapy

Introduction

Delphine Gabrielle Josette Rea is a prominent inventor based in Leiden, Netherlands. She has made significant contributions to the field of immunotherapy, particularly through her innovative research on dendritic cells. Her work focuses on enhancing immune responses and developing novel therapeutic methods.

Latest Patents

Delphine Rea holds a patent titled "Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigen-specific T cell responses." This invention provides novel methods for immunotherapy by offering immune cells and methods to generate them, which can reduce an immune response in a host. The patent outlines a method for generating dendritic cells that can tolerize T-cells for specific antigens, involving the culturing of peripheral blood monocytes and their activation in the presence of glucocorticoid hormones.

Career Highlights

Delphine Rea is affiliated with Leids Universitair Medisch Centrum, where she conducts her research and develops her innovative ideas. Her work has garnered attention in the scientific community, contributing to advancements in immunotherapy.

Collaborations

Delphine collaborates with esteemed colleagues, including Cornelis Johannes Maria Melief and Rienk Offringa. These partnerships enhance her research and broaden the impact of her innovations in the field.

Conclusion

Delphine Gabrielle Josette Rea is a trailblazer in the realm of immunotherapy, with her patent and research paving the way for future advancements. Her contributions are vital to the ongoing development of effective therapeutic methods.